Laparotomy versus minimally invasive surgery for interval debulking surgery among patients with advanced ovarian cancer

To assess the impact of the surgical route for interval surgery after neoadjuvant chemotherapy on overall and 5-year survival, 30- and 90-day mortality, length of stay, readmission rate, and residual disease among patients with advanced epithelial ovarian cancer.